ING Groep's second quarter of 2026 delivered the kind of results that affirm a bank's fundamental health — double-digit revenue growth, strong returns on capital, and management confident enough to raise its forward outlook. Yet markets, in their perpetual anticipation of good news, had already priced much of this strength into the shares. The story here is not one of failure, but of a timeless tension in investing: when reality meets expectation, the question shifts from whether a business is good to whether its price still offers a journey worth taking.